Kraig Biocraft Laboratories, Inc.
KBLB
$0.14
$0.001.05%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 653.90K | 1.42M | 573.90K | 556.60K | 655.40K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 722.70K | 1.43M | 637.70K | 580.50K | 715.90K |
| Operating Income | -722.70K | -1.43M | -637.70K | -580.50K | -715.90K |
| Income Before Tax | -787.60K | -1.51M | -726.10K | -600.00K | -851.70K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -787.60K | -1.51M | -726.10K | -600.00K | -851.70K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -787.60K | -1.51M | -726.10K | -600.00K | -851.70K |
| EBIT | -722.70K | -1.43M | -637.70K | -580.50K | -715.90K |
| EBITDA | -715.10K | -1.43M | -631.90K | -574.80K | -709.90K |
| EPS Basic | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 1.08B | 1.07B | 1.05B | 1.04B | 1.04B |
| Average Diluted Shares Outstanding | 1.08B | 1.07B | 1.05B | 1.04B | 1.04B |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |